⌘K

Login Start Free

Home/Filings/4/0001144204-16-127046

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-127046

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:30 PM ET

Size

5.2 KB

Accession

0001144204-16-127046

Insider Transaction Report

Form 4

Period: 2016-10-03

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Award
Stock Options (Right to Buy)
2016-10-03+308,571→ 308,571 total
Exercise: $1.11From: 2016-10-03Exp: 2026-10-03→ Common Stock (308,571 underlying)

Documents

1 file

4
v450066_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 4:30 PM ET
Size: 5.2 KB

View on SEC.gov